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Clinic, Courtroom or (Specialist) Committee: In the Best Interests of the Critically Ill Child?  
 
Abstract 
Law’s processes are likely always to be needed when particularly intractable conflicts arise in 
relation to the care of a critically ill child like Charlie Gard. Recourse to law has its merits, but it also 
imposes costs, and the courts’ decisions about the best interests of such children appear to suffer 
from uncertainty, unpredictability and insufficiency. The insufficiency arises from the courts’ 
apparent reluctance to enter into the ethical dimensions of such cases. Presuming that such 
reflection is warranted, this article explores alternatives to the courts, and in particular the merits of 
specialist ethics support services, which appear to be on the rise in the UK. Such specialist services 
show promise, as they are less formal and adversarial than the courts and they appear capable of 
offering expert ethical advice. However, further research is needed into such services – and into 
generalist ethics support services – in order to gauge whether this is indeed a promising 
development. 
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INTRODUCTION  
One of the few positive outcomes of the Gard litigation is that it re-focused public attention on 
“what we mean by best interests … and how they are best served”.[1] There is value in such public 
reflection, but neither a metaphoric court of public opinion,[2] nor a literal court of law, appear to 
be ideal locations for determining the care of a critically ill child.  
In this article, I initially explain the legal lenses through which such difficult cases are viewed and, 
whilst acknowledging their strengths, highlight some of the courts’ weaknesses. Recourse to law 
imposes various costs and the judges’ attempts to determine the best interests of children also 
reveal the law to be uncertain, unpredictable and insufficient. The insufficiency arises from the law’s 
apparent reluctance to address the ethical dimensions of such decisions.  
Assuming ethical reflection is warranted, I explore the strengths and weaknesses of clinical ethics 
support services, focussing on the merits of investing – whether at local, regional or national levels – 
in specialist ethics services. Such services, which are developing in the UK, have as their core 
business the provision of ethical advice as to the best interests of critically ill children like Charlie 
Gard. They are unlikely to replace the courts in particularly intractable cases: notably, such specialist 
advice was available in the hospital caring for Gard, but still his case went to court. Yet, specialist 
ethics support shows promise and might reduce the need for legal recourse. Before advancing this 
hypothesis, which I hope will spur further research, I start with an outline and assessment of the law 
in this area.  
 
FROM THE CLINIC TO THE COURTROOM  
English law typically views cases like Gard through three sets of lenses, which derive from the 
criminal law, civil (family) law, and human rights law.  
The criminal law comes first in this selective (non-treatment) retrospective.[3] Homicide law has long 
confirmed that a fatal failure to meet a duty to care for a dependent can amount to murder or 
manslaughter, depending on the accused’s intention or knowledge.[4, 5] The last pertinent trial of a 
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doctor was in 1981. Dr Arthur was acquitted of the attempted murder of John Pearson, a new-born 
with Down’s syndrome. The paediatrician allegedly wrote “Parents do not wish the baby to survive. 
Nursing care only” and prescribed the painkiller DF118; the child died 69 hours later.[6] Summing up 
to the jury, Farquharson J emphasised the absence of any “special law” protecting doctors,[6 p5] but 
noted the lawfulness of some omissions and of symptom relief, plus the good character and motives 
of the defendant, who had apparently been following accepted practice.   
Farquharson J was evidently uncomfortable viewing this doctor’s behaviour through the criminal law 
lens,[3] and a different legal lens has indeed since been used. The civil – specifically family – law lens 
had actually been adopted in a ruling weeks before Farquharson J’s direction, although it was not 
cited by him. In Re B, the Court of Appeal decided that life-saving surgery was in the “best interests” 
of another new-born with Down’s syndrome, as it was not the case that “the life of this child is 
demonstrably going to be so awful that in effect the child must be condemned to die”.[7]  
This focus on the “best interests” or – following the Children Act 1989 – “welfare” of the critically ill 
child has led the way since. The 1989 Act holds that “the child’s welfare shall be the court’s 
paramount consideration”.[8] Welfare is not defined, but the factors to consider when making such 
a judgment include “the ascertainable wishes and feelings of the child”, his or her “physical, 
emotional and educational needs” and “any harm” he or she has suffered or is at risk of suffering.[9] 
Using the (synonymous[10]) welfare or best interests tests, the courts have frequently decided that 
life-sustaining treatment is not indicated.[11] The Court of Appeal has emphasised that the test is 
indeed the best interests or welfare of the child:[12, 13] references to an “intolerably” poor or 
“demonstrably … awful” quality of life are not to be treated as glosses on the test.[14] Despite such 
warnings, the Court of Appeal has helpfully indicated the basic approach:  
“The judge must decide what is in the child’s best interests. In making that decision, the 
welfare of the child is paramount, and the judge must look at the question from the 
assumed point of view of the patient. There is a strong presumption in favour of a course of 
action which will prolong life, but that presumption is not irrebuttable. The term ‘best 
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interests’ encompasses medical, emotional, and all other welfare issues. The court must 
conduct a balancing exercise in which all the relevant factors are weighed and a helpful way 
of undertaking this exercise is to draw up a balance sheet”.[15 para 87] 
This statement was made in Wyatt, a widely-publicised and difficult case, which generated no fewer 
than 11 rulings.[16 p187]  
By the time of Wyatt, a third, human rights, lens had been overlaid on top of the family law lens, via 
the Human Rights Act 1998, which effectively brought the European Convention on Human Rights 
directly into English law. The judges thereafter confirmed that decisions taken in the best interests 
of the child would not violate any of the human rights therein.[17] However, the fraught case of 
Glass, which reached the European Court of Human Rights, emphasised that parents had a right to 
consent to treatment, under article 8 (the right to respect for private and family life), and that 
appropriate efforts should be made to settle disputes – including by calling on the courts when 
needed.[18] 
 
THE LIMITS OF LAW  
The courts, equipped with the relevant legal principles and processes, have a legitimate role in 
resolving (non-)treatment disputes. Law will obviously have a view on life-or-death cases and the 
courts are there to settle disputes; given the magnitude of some of the disagreements, which 
involved fistfights between family members and healthcare staff in Glass,[19] this sort of external – 
and authoritative – judgment seems appropriate. Perhaps, like Glass, Wyatt and the more recent 
case of King,[20] Gard was also a case that rightly landed in court. The courts are not overwhelmed 
here,[21 p207] so maybe all is as it should be. Yet, whether a court is indeed the best place to 
resolve such dilemmas is questionable.  
Recourse to law imposes various costs on the parties and others. First, there are financial costs to 
the health service and, by extension, other patients: a PICU bed reportedly costs more than £2,000 
per day.[22, 23] Secondly, there are the legal costs, which are not necessarily covered by Legal 
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Aid.[24 para 17] Thirdly, legal action can be stressful and distressing for the parties, particularly given 
law’s adversarial win-or-lose mentality. Meller and Barclay point to Wyatt, which  
“ended in a lose-lose-lose situation: an embittered and fragmented family, a child in foster 
care and six-figure costs for the hospital trust. The medical staff were left feeling battered 
and bruised and there was no real closure to this tragic case”.[25 p620]  
Finally, although High Court judges are available at any hour, proceedings will typically take time, 
which could come at the expense of the child’s interests.  
This, of course, assumes that we can ascertain where the best interests of a child lie. Unfortunately, 
the law informing (and making) such determinations is uncertain, unpredictable, and arguably 
insufficient. First, the law here falls short of issuing the clear and consistent action-guiding rules 
required of a functioning legal system.[26] The rule initially appears clear: the welfare or best 
interests of the child is the paramount concern. However, the rule is also opaque: the factors guiding 
such a determination are only enumerated, as opposed to elaborated, with decisions taken on a 
case-by-case basis.[27] The judges enjoy considerable discretion,[28] and apparently similar cases 
have resulted in different outcomes.[11] Such flexibility might mean the law is commendably 
pluralistic – but the resultant uncertainty also reveals the “greatest weakness” of the standard.[29 
p173]  
Uncertainty means, secondly, that the law is unpredictable. Certainly, some trends are detectable: 
for example, the children of Jehovah’s witnesses will typically be transfused despite their parents’ 
objections,[30, 31] and, more generally, doctors’ views will usually trump those of parents.[11 p89] 
However, the latter does not always hold true.[32]  
Finally, the law in this area appears insufficient. These are “cases of ethical complexity”.[25 p619] 
Some judges acknowledge and engage with these dimensions,[33] but others are reluctant to do so 
(at least, openly),[34 p969] with Montgomery complaining of the resultant “de-moralisation” of 
healthcare law.[35] Perhaps law can only provide minimal standards,[36] but the ethical dimensions 
arguably should be aired and, if possible, resolved.  
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FROM THE COURTROOM (BACK) TO THE CLINIC 
The law, therefore, has its limits. Commenting on Wyatt, Brazier noted that adjudication might 
“exacerbate a tragedy nature created. But is there any alternative?”[37] Three alternatives come to 
mind, each of which has its strengths, but also its weaknesses. 
A first alternative points to prevention. Birchley’s study found professionals to be reluctant to 
approach the courts,[38] with one nurse participant stating:  
“the last, last thing you want to do is go to court… if we can compromise before we get 
there, if we can talk to the family and we give them time to come to situations, or we may 
come – we may change our minds as well”.[39]  
The courts and professional guidance similarly emphasise the importance of good communication 
and shared decision-making,[12, 40] which might deter disputes from arising or escalating. Training 
professionals in communication skills, as well as in how to recognise, understand and manage 
conflict,[41] might therefore help avoid or quell disputes.  
Yet, further alternatives will be needed if disputes nevertheless arise. A second alternative found 
support in Gard, wherein Francis J offered the  
“clear view that mediation should be attempted in all cases such as this one even if all that it 
does is achieve a greater understanding by the parties of each other’s positions”.[24 para 
20] 
The use of mediation in these cases has also been promoted by Meller and Barclay,[25] and was 
commended in a Nuffield Council on Bioethics report, which recommended research into its possible 
benefits.[42 para 8.56–8.62 and 9.39]  
Mediation might well avoid some of the costs of legal proceedings and could potentially enhance 
understanding and trust between the participants, so further exploration of its possible benefits 
certainly seems merited. However, like the courts, mediation will generate case-specific outcomes, 
which will not necessarily attend sufficiently to the complex ethical issues. Assuming these ethical 
 7 
 
dimensions should be addressed, a further alternative is required, and it is on this I wish to focus (as 
distinct from, but without denying the possible benefits of, the preceding approaches).  
The means to explore the ethical dimensions of ethically difficult cases already exist, typically (in the 
UK) taking the form of clinical ethics committees (CEC). The UK Clinical Ethics Network (UKCEN), the 
charity which promotes ethics support and facilitates contact between CECs, describes CECs as  
“multidisciplinary groups, including health professionals and lay members that aim to 
provide support for decision-making on ethical issues arising from the provision of patient 
care within NHS Trusts and other health care institutions”.[43] 
From 20 committees in 2000, there are reportedly 85 committees currently known to UKCEN.[43]  
CECs certainly appear to have their merits.[11] First, CECs seek to provide practical advice, thus 
neither amounting to a mere “talking shop”, nor posing a threat to clinical autonomy. Secondly, as 
UKCEN noted, they are designed to be supportive: salient expertise is pooled and shared, and the 
processes are less formal than those of the courts. Thirdly, CECs explicitly seek to explore the ethical 
aspects of the particular referral. Indeed, UK CECs, like others worldwide,[44] notably tend to be 
consulted about such issues as withholding or withdrawing treatment, and thus precisely the cases 
we have in view.[43] Many CECs therefore have the experience – perhaps even the expertise – 
needed to help resolve dilemmas in this context.  
CECs therefore have some advantages over courts, as they might be quicker to issue their advice, 
less costly (in various senses), and are more inclusive and less adversarial, at least if we accept 
Reiter-Theil’s observation that “the language of ethics can serve as a common language in which 
conflicting viewpoints can be discussed”.[45] Furthermore, in contrast to the courts’ occasional 
reluctance, ethical reflection is at the heart of the CEC endeavour. 
CECs therefore show promise but, like the courts, they also have their problems. First, there are 
problems of orientation. CECs primarily exist to support clinicians, which prompts questions about 
their commitment (and availability) to patients and families,[46] their independence from the 
healthcare institution,[47] and their accountability.[48] Secondly, there are problems of operation 
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and process. Membership – including lay membership – is a vexed question,[49] as are 
qualifications, certification, competencies,[50] and deliberative frameworks.[51] McLean, a 
healthcare lawyer, has dubbed CECs a “due process wasteland”,[52] asking: “what and who are 
clinical ethics committees for?”[53] Thirdly, there are problems of impact and evaluation, prompting 
questions about the value and utilisation of CECs.[54]  
 
TOWARDS SPECIALIST CLINICAL ETHICS SUPPORT  
Further research into the questions surrounding CECs is undoubtedly needed, especially in the UK. 
Pending that, however, I hypothesise that specialist clinical ethics support services might offer a way 
forward, which could address some of the deficiencies of existing CECs, whilst also avoiding those 
associated with the courts.  
Many existing UK CECs are generalists, accepting referrals from a range of contexts and clinical 
specialties. Models for more focussed support services nevertheless exist, both at the micro (local) 
and the macro (regional or national) levels. Some CECs already focus on particular clinical contexts, 
such as mental health care, palliative care, and reproductive services.[55] There are also regional 
and national fora: for example, the Doyle Club, for palliative care professionals, accommodates 
ethical reflection, while the Genethics Club,[56] established in 2001, provides “a national forum of 
ethics support for the profession of clinical genetics in the UK”.[57]  
These sorts of micro and macro developments are also occurring in relation to the care of critically ill 
children. Great Ormond Street Hospital (GOSH), the Trust embroiled in the Gard case, has a clinical 
ethics service, which has been increasingly utilised since 2012, sometimes by other UK paediatric 
services.[58] Its co-chair also chairs the recently-formed Child Health Ethics and Law Special Interest 
Group (CHELSIG), “a multidisciplinary professionals group seeking to explore ethical and legal issues 
affecting children and their healthcare”, which, like Genethics Club, meets around the UK.[59] 
Such specialist ethics support appears promising. First, the relative informality of ethics services, 
which are intended to be supportive, should impose fewer costs than calling on the courts, thus 
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saving time, money and heartache. Generalist ethics support might also have these advantages, but 
a specialist service has notably been commended in this regard. During its GOSH visit, the Care 
Quality Commission (CQC) spoke with a parent who had attended a CEC meeting, who “felt this was 
an appropriate course of action and said ‘the process was not too daunting’”.[60 p106] 
Secondly, the requisite membership of a specialised service might be more readily apparent than 
that of a generalist service. Various professionals – including doctors, nurses and various allied 
health professionals – will still be needed, but these need not cover a diverse array of clinical 
contexts, from conception to old age. Rather, in our context, the professional members should all 
have the expertise to care for sick children and their families. The necessary “lay” membership 
should also be apparent: at a minimum, parents of (current or previous) critically ill patients should 
be included.1 Notably, GOSH’s service has such a parent as co-chair.[58 p16] Securing such input, 
particularly at the highest level of the service, could help to ensure that the service is oriented 
towards patients and families, not just clinicians.  
Thirdly, and crucially, a suitably composed specialist service might be more capable than the courts 
or generalist ethics services of providing relevant practice-oriented ethical advice. Lucassen and 
Parker note that laws are typically general and in need of interpretation: by undertaking “detailed 
examination of the nuances of clinical cases”, a specialist forum like Genethics Club offers “ongoing 
practical support” and “clear courses of action in a particular case”.[57 pp 220, 223] 
Of course, specialist services will need to be equipped to provide the relevant ethical advice. CECs 
need “critical teeth”,[61] and thus competencies in, and models for, ethical deliberation. Models 
abound worldwide, including from the UK (the Ethox (Oxford) model),[62] the US (the four principles 
and four quadrants approaches),[63, 64] the Netherlands (moral case deliberation),[65] Denmark 
(the ICU-focused “4 C’s” approach),[66] and Singapore (the “A, B, C” approach, which was developed 
                                                          
1 Alongside children and young people themselves, plus academic bioethicists with experience in the relevant 
field.  
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with a British bioethicist).[67] Yet, empirical research, including in the UK, reveals that there is 
plurality even within a single country or indeed committee.[51, 68]  
Consistency, certainty and predictability might therefore remain just as much problems for specialist 
services as for courts. However, the specialist focus of such a service could enhance consistency in 
decision-making. Although it is a contentious issue,[69] to which I will return, a specialist body might 
even develop and apply a sort of expertise, beyond that exhibited in generalist ethics services. 
Lucassen and Parker hint at this when they suggest that “clinical genetic practice, with its focus on 
familial issues, remains an unusual aspect of Hospital Clinical Ethics Committee work and some 
committees may feel that they lack the expertise to inform practice”.[57 p221]  
Applied to the current context, a specialist service seems capable, specifically, of offering expert 
advice on the best interests of a critically ill child. An ethics service, tasked with offering ethical 
advice, can therefore go beyond mere enumeration of the salient features of a particular referral, 
into elaboration of how the child’s best interests should be understood and effectuated.[27] 
Philosophical accounts of best interests or welfare vary in their foci, looking to what people want 
(desire accounts), like (hedonistic accounts) or need (objective accounts).[70] By focussing on a 
reasonably specified range of cases, a specialist service could advance thinking in this area and – 
provided that due attention is given to due process – build up a body of knowledge that is capable of 
consistent application. According to Annas, “good ethics committees begin where the law ends”,[71] 
but their knowledge and experience could prove valuable both to the courts and to bioethics. As 
rulings in other jurisdictions indicate,[72, 73, 74] the courts might welcome the injection of specialist 
ethical reflection, while normative thinking about these sorts of cases might also be enhanced by the 
insights emanating from the crucible of experience. 
Fourthly, and linked to these latter points, the provision of specialist services could help with efforts 
to evaluate the impact of ethics support. The CQC report on GOSH revealed one way of measuring 
impact: “The ethics service enables resolution without going to court”.[60 p106] The report noted 
that “Some cases were taken to court for a Judge’s decision when a consensus could not be made 
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through the ethics committee. These cases however were rare”.[60 p102] These observations 
implicitly recognise that a (specialist) ethics service might provide measurable benefits – although 
this is only one example, and no doubt much more evidence (of this and other sorts) would be 
needed to demonstrate the (positive?) effect of such services.  
Indeed, these claims about the merits of a specialist ethics service all need to be explored and 
tested. The drawbacks of a specialist model will also need investigation. Some potential problems 
might afflict specialist and generalist services alike, such as those surrounding conflicts of interest, 
accountability, qualifications, certification and, generally, due process.2 Law, of course, is fixated on 
due process, so there might be legal lessons (for example, on the use of “precedents”) to be 
learnt.[75] But specialist support services will also confront more specific questions, three of which I 
will mention here.  
First, what should be the scope of a specialist service? And might there be risks of (and in) super-
specialisation? A specialist service could focus on children, but it might more narrowly focus on (for 
example) children in particular age groups, children with particular conditions, or non-treatment as 
opposed to treatment decisions in relation to children. There is an echo here of the rise of 
specialised academic ethical reflection, revealed by the proliferation of “X-ethics” fields and journals. 
Might any narrowing of focus mean that something – such as relevant learning by analogy – will be 
lost?  
Secondly, what should be the location – and geographical reach – of a specialist committee? Should 
this be nationally, regionally or locally situated? Again, something might be lost if services are too 
centralised or are otherwise too distanced from the place of caregiving; for example, one argument 
in favour of localised ethics support is that a locally-based service will have pertinent knowledge of 
institutional, geographical and clinical context.  
                                                          
2 Including reporting back to participants in the referral (see [60 p106])  and ensuring there is (appropriate) 
transparency; my thanks to Riordan Deehan-Jackson for emphasising the last point to me.  
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Thirdly, specialist services force (re-)engagement with the vexed question of ethical expertise: what 
expertise might – or should – a specialist committee and its members be expected to have?  
The case for a specialist service seems to hinge on it having relevant expertise in relation to the 
problems coming before it and relevant expertise in the ethical analysis thereof. Of course, 
questions immediately arise about what amounts to “relevant expertise”, who is “experienced” in 
the relevant ways and what “such problems” are (i.e. the aforementioned remit of the committee). 
As noted, relevantly experienced people would include those with lived experience of dealing with 
such problems, such as affected parents and appropriately qualified clinicians. Ethical expertise is 
more problematic. What sort of expertise is this, who – if anyone – possesses it, and why, in 
particular, should anyone listen to a clinical ethicist?[76],[77] Some bioethicists argue that moral 
philosophers are “experts in matters of morals”,[78 p117] but many in the field disagree.[79] 
Whether or not they can be considered moral(ising?) experts, bioethicists working as clinical 
ethicists are likely to have pertinent skills in clarifying and negotiating ethical claims, suggesting 
there is a case for their inclusion in specialist services.[11] However, here too we might wonder who 
counts as a “bioethicist” or “clinical ethicist” in the relevant sense and whether such a person(s) 
should have specialist knowledge of the specific problems the service will address. More generally, 
even if specialist services can develop and exercise a sort of expertise, they could risk becoming 
inappropriately insular and stuck in their ways.  
Questions like these deserve further consideration. It nevertheless appears that ethics support, and 
specialist ethics support in particular, has its merits, including the possible avoidance of legal 
proceedings in cases like Gard.  
 
CONCLUSION  
GOSH, of course, arguably had a specialist ethics service and yet Gard still came to be decided in a 
courtroom. This reinforces the need for further research into the strengths and weaknesses of such 
services. Law’s processes will likely always be needed in particularly intractable cases. Yet, if 
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specialist ethics support services can deliver on their apparent promise, it may be – as the CQC 
found in relation to GOSH – that recourse to the courts will be rare. The courts, backed by well-
developed processes, are there to decide when needed, but they are costly (in various senses), and 
their decisions about the best interests of critically ill children appear to suffer from uncertainty, 
unpredictability and insufficiency. Amongst the alternatives available, specialist ethics support 
services show particular promise, as they are less formal and adversarial than the courts and they 
appear capable of offering expert ethical advice. Questions nevertheless surround such services, and 
indeed generalist ethics support services, so further research is needed to gauge whether this sort of 
ethics support is indeed a promising development.  
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